Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Kathrin Renner(University Hospital Regensburg), Marina Kreutz(University Hospital Regensburg)
Cited by 367
Related Papers
New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
|PLoS ONE|2013|118
D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells
|International Journal of Molecular Sciences|2019|27
LDHB Overexpression Can Partially Overcome T Cell Inhibition by Lactic Acid
|International Journal of Molecular Sciences|2022|27
D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells
|Haematologica|2024|13
Physiological levels of 25‐hydroxyvitamin D<sub>3</sub> induce a suppressive CD4<sup>+</sup> T cell phenotype not reflected in the epigenetic landscape
|Scandinavian Journal of Immunology|2022|7